ENDOCRINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2198589, encodeId=40032198589dc, content=请问一般多久online呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e7c5623450, createdName=ms5000001120338885, createdTime=Mon Apr 15 12:16:42 CST 2024, time=昨天, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197423, encodeId=d521219e4230e, content=请问Technical check后面是Peer review，Peer review已经持续一个月了，是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13069193199, createdName=ms6000000830172102, createdTime=Mon Apr 08 17:37:43 CST 2024, time=2024-04-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：甲状腺 经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺肿瘤 经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西)]

昨天 ms5000001120338885 来自重庆

请问一般多久online呀

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2198589, encodeId=40032198589dc, content=请问一般多久online呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e7c5623450, createdName=ms5000001120338885, createdTime=Mon Apr 15 12:16:42 CST 2024, time=昨天, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197423, encodeId=d521219e4230e, content=请问Technical check后面是Peer review，Peer review已经持续一个月了，是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13069193199, createdName=ms6000000830172102, createdTime=Mon Apr 08 17:37:43 CST 2024, time=2024-04-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：甲状腺 经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺肿瘤 经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西)]

2024-04-08 ms6000000830172102 来自安徽省

请问Technical check后面是Peer review，Peer review已经持续一个月了，是送审了吗？

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2198589, encodeId=40032198589dc, content=请问一般多久online呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e7c5623450, createdName=ms5000001120338885, createdTime=Mon Apr 15 12:16:42 CST 2024, time=昨天, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197423, encodeId=d521219e4230e, content=请问Technical check后面是Peer review，Peer review已经持续一个月了，是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13069193199, createdName=ms6000000830172102, createdTime=Mon Apr 08 17:37:43 CST 2024, time=2024-04-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：甲状腺 经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺肿瘤 经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西)]

2024-03-10 Bandore 来自广东省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：甲状腺
经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。

1 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198589, encodeId=40032198589dc, content=请问一般多久online呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e7c5623450, createdName=ms5000001120338885, createdTime=Mon Apr 15 12:16:42 CST 2024, time=昨天, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197423, encodeId=d521219e4230e, content=请问Technical check后面是Peer review，Peer review已经持续一个月了，是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13069193199, createdName=ms6000000830172102, createdTime=Mon Apr 08 17:37:43 CST 2024, time=2024-04-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：甲状腺 经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺肿瘤 经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西)]

2024-04-03 1234456789 来自江苏省

还没投

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2198589, encodeId=40032198589dc, content=请问一般多久online呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e7c5623450, createdName=ms5000001120338885, createdTime=Mon Apr 15 12:16:42 CST 2024, time=昨天, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197423, encodeId=d521219e4230e, content=请问Technical check后面是Peer review，Peer review已经持续一个月了，是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13069193199, createdName=ms6000000830172102, createdTime=Mon Apr 08 17:37:43 CST 2024, time=2024-04-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：甲状腺 经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺肿瘤 经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西)]

2024-04-01 1234456789 来自江苏省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：在投中

9 0

[GetPortalCommentsPageByObjectIdResponse(id=2198589, encodeId=40032198589dc, content=请问一般多久online呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e7c5623450, createdName=ms5000001120338885, createdTime=Mon Apr 15 12:16:42 CST 2024, time=昨天, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197423, encodeId=d521219e4230e, content=请问Technical check后面是Peer review，Peer review已经持续一个月了，是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13069193199, createdName=ms6000000830172102, createdTime=Mon Apr 08 17:37:43 CST 2024, time=2024-04-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：甲状腺 经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺肿瘤 经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西)]

2024-03-12 ms2000000185262432 来自广西

审稿速度:6.0 | 投稿命中率:5.0
偏重的研究方向：甲状腺肿瘤
经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了

13 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198589, encodeId=40032198589dc, content=请问一般多久online呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e7c5623450, createdName=ms5000001120338885, createdTime=Mon Apr 15 12:16:42 CST 2024, time=昨天, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197423, encodeId=d521219e4230e, content=请问Technical check后面是Peer review，Peer review已经持续一个月了，是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13069193199, createdName=ms6000000830172102, createdTime=Mon Apr 08 17:37:43 CST 2024, time=2024-04-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：甲状腺 经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺肿瘤 经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西)]

2024-03-14 1234456789 来自江苏省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：在投

9 0

[GetPortalCommentsPageByObjectIdResponse(id=2198589, encodeId=40032198589dc, content=请问一般多久online呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e7c5623450, createdName=ms5000001120338885, createdTime=Mon Apr 15 12:16:42 CST 2024, time=昨天, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197423, encodeId=d521219e4230e, content=请问Technical check后面是Peer review，Peer review已经持续一个月了，是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13069193199, createdName=ms6000000830172102, createdTime=Mon Apr 08 17:37:43 CST 2024, time=2024-04-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：甲状腺 经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺肿瘤 经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西)]

2024-03-06 1234456789 来自江苏省

投稿命中率:25.0
经验分享：在投

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198589, encodeId=40032198589dc, content=请问一般多久online呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e7c5623450, createdName=ms5000001120338885, createdTime=Mon Apr 15 12:16:42 CST 2024, time=昨天, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197423, encodeId=d521219e4230e, content=请问Technical check后面是Peer review，Peer review已经持续一个月了，是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13069193199, createdName=ms6000000830172102, createdTime=Mon Apr 08 17:37:43 CST 2024, time=2024-04-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：甲状腺 经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺肿瘤 经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西)]

2021-03-16 ms1000001155806208

求该期刊的参考文献格式，谢谢！

69 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198589, encodeId=40032198589dc, content=请问一般多久online呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e7c5623450, createdName=ms5000001120338885, createdTime=Mon Apr 15 12:16:42 CST 2024, time=昨天, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197423, encodeId=d521219e4230e, content=请问Technical check后面是Peer review，Peer review已经持续一个月了，是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13069193199, createdName=ms6000000830172102, createdTime=Mon Apr 08 17:37:43 CST 2024, time=2024-04-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：甲状腺 经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺肿瘤 经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0 经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西)]

2024-01-26 水逆退散～来自广西

偏重的研究方向：甲状腺
经验分享：2024.1.25 editor appointed

21 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务